bivalirudin是一种抗凝药物，通常用于在接受介入治疗（如心脏搭桥手术或支架植入）的患者中防止血栓形成。在一些医学文献和临床试验中，bivalirudin被用于替代传统的肝素类药物。
以下是一篇关于bivalirudin的英文范文：
Bivalirudin in Interventional Cardiology: A Review.
Bivalirudin is a synthetic derivative of the peptide bradykinin receptor antagonist. It is used as an anticoagulant in patients undergoing interventional cardiology procedures, such as coronary stenting and heart bypass surgery, to prevent blood clotting. Compared with traditional heparin, bivalirudin has a faster onset of action, a lower incidence of heparin-induced thrombocytopenia, and a more predictable risk-benefit ratio.
In clinical trials, bivalirudin provided effective and safe anticoagulation in patients undergoing various interventional cardiology procedures, with a low incidence of bleeding complications. Additionally, bivalirudin has been shown to be well tolerated in combination with various antiplatelet agents, including aspirin and clopidogrel.
Overall, bivalirudin is a safe and effective alternative to traditional heparin for anticoagulation in patients undergoing interventional cardiology procedures. It provides faster and more predictable anticoagulation compared with heparin, with a lower incidence of bleeding complications.
bivalirudin是一种抗凝药物，通常用于在接受介入治疗（如心脏导管插入术）的患者中防止血栓形成。在英文范文当中，bivalirudin可能会被用于手术后的血液稀释和防止血栓形成。此外，bivalirudin也可以用于需要长期抗凝治疗的患者，如接受心脏瓣膜手术或存在其他高风险形成血栓的患者。
bivalirudin是一种抗凝药物，通常用于在手术或心导管过程中减少血液凝结的风险。在英文范文中的使用通常与医疗、手术或心血管相关的上下文中。
关于bivalirudin英文范文最新变化，目前没有特定的信息，因为该药物的使用和变化通常取决于特定的医疗环境和情况。建议查阅最新的医学文献或与医疗专业人员咨询以获取有关bivalirudin在英文范文中的最新使用和变化的信息。